Síndrome de VEXAS: manifestaciones clínicas, diagnóstico y tratamiento.

Saved in:
Bibliographic Details
Title: Síndrome de VEXAS: manifestaciones clínicas, diagnóstico y tratamiento.
Authors: Loeza-Uribe, Michelle Patricia1 (AUTHOR), Hinojosa-Azaola, Andrea1 (AUTHOR), Sánchez-Hernández, Beatriz E.2 (AUTHOR), Crispín, José C.1 (AUTHOR), Apodaca-Chávez, Elia3 (AUTHOR), Ferrada, Marcela A.1,4 (AUTHOR) marcela.ferrada@nih.gov, Martín-Nares, Eduardo1 (AUTHOR) eduardomartinnares@gmail.com
Source: Reumatología Clínica. Jan2024, Vol. 20 Issue 1, p47-56. 10p.
Subjects: PURE red cell aplasia, STEM cell transplantation, SWEET'S syndrome, POLYARTERITIS nodosa, SYMPTOMS, MYELODYSPLASTIC syndromes
Abstract: El síndrome de VEXAS (Vacuolas, enzima E1, ligado al X, Autoinflamatorio, Somático) es un síndrome autoinflamatorio de inicio en la edad adulta que se caracteriza por mutaciones somáticas en el gen UBA1 y se considera el prototipo de enfermedad hematoinflamatoria. Los pacientes con síndrome de VEXAS exhiben manifestaciones inflamatorias y hematológicas que pueden conducir a diagnósticos clínicos como policondritis recidivante, poliarteritis nodosa, síndrome de Sweet y síndrome mielodisplásico. El diagnóstico requiere la evaluación de la médula ósea en búsqueda de vacuolas citoplásmicas en precursores mieloides y eritroides. Sin embargo, la confirmación genética de las mutaciones en UBA1 es necesaria. El tratamiento es un desafío y a menudo incluye glucocorticoides e inmunosupresores, con respuestas variables. Las terapias hipometilantes y el trasplante alogénico de células progenitoras hematopoyéticas se consideran terapias prometedoras. El pronóstico es influido por factores genéticos y clínicos. El objetivo de esta revisión es proporcionar una visión general sobre la patogénesis, la presentación clínica, el tratamiento y el pronóstico del síndrome de VEXAS para la comunidad médica latinoamericana. VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is an adult-onset autoinflammatory syndrome characterized by somatic mutations in the UBA1 gene and is considered the prototype of hematoinflammatory diseases. Patients with VEXAS syndrome exhibit inflammatory and hematological manifestations that can lead to clinical diagnoses such as relapsing polychondritis, polyarteritis nodosa, Sweet syndrome, and myelodysplastic syndrome. Diagnosis requires bone marrow evaluation to identify cytoplasmic vacuoles in myeloid and erythroid precursors. However, genetic confirmation of mutations in UBA1 is necessary. Treatment is challenging and often involves glucocorticoids and immunosuppressants with variable responses. Hypomethylating agents and allogenic haemopoietic stem cell transplant are considered promising therapies. Prognosis is influenced by genetic and clinical factors. The aim of this review is to provide an overview of the pathogenesis, clinical presentation, treatment, and prognosis of VEXAS syndrome for the Latin American medical community. [ABSTRACT FROM AUTHOR]
Copyright of Reumatología Clínica is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 174317512
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Síndrome de VEXAS: manifestaciones clínicas, diagnóstico y tratamiento.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Loeza-Uribe%2C+Michelle+Patricia%22">Loeza-Uribe, Michelle Patricia</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hinojosa-Azaola%2C+Andrea%22">Hinojosa-Azaola, Andrea</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sánchez-Hernández%2C+Beatriz+E%2E%22">Sánchez-Hernández, Beatriz E.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Crispín%2C+José+C%2E%22">Crispín, José C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Apodaca-Chávez%2C+Elia%22">Apodaca-Chávez, Elia</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ferrada%2C+Marcela+A%2E%22">Ferrada, Marcela A.</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<i> marcela.ferrada@nih.gov</i><br /><searchLink fieldCode="AR" term="%22Martín-Nares%2C+Eduardo%22">Martín-Nares, Eduardo</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> eduardomartinnares@gmail.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Reumatología+Clínica%22">Reumatología Clínica</searchLink>. Jan2024, Vol. 20 Issue 1, p47-56. 10p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22PURE+red+cell+aplasia%22">PURE red cell aplasia</searchLink><br /><searchLink fieldCode="DE" term="%22STEM+cell+transplantation%22">STEM cell transplantation</searchLink><br /><searchLink fieldCode="DE" term="%22SWEET'S+syndrome%22">SWEET'S syndrome</searchLink><br /><searchLink fieldCode="DE" term="%22POLYARTERITIS+nodosa%22">POLYARTERITIS nodosa</searchLink><br /><searchLink fieldCode="DE" term="%22SYMPTOMS%22">SYMPTOMS</searchLink><br /><searchLink fieldCode="DE" term="%22MYELODYSPLASTIC+syndromes%22">MYELODYSPLASTIC syndromes</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: El síndrome de VEXAS (Vacuolas, enzima E1, ligado al X, Autoinflamatorio, Somático) es un síndrome autoinflamatorio de inicio en la edad adulta que se caracteriza por mutaciones somáticas en el gen UBA1 y se considera el prototipo de enfermedad hematoinflamatoria. Los pacientes con síndrome de VEXAS exhiben manifestaciones inflamatorias y hematológicas que pueden conducir a diagnósticos clínicos como policondritis recidivante, poliarteritis nodosa, síndrome de Sweet y síndrome mielodisplásico. El diagnóstico requiere la evaluación de la médula ósea en búsqueda de vacuolas citoplásmicas en precursores mieloides y eritroides. Sin embargo, la confirmación genética de las mutaciones en UBA1 es necesaria. El tratamiento es un desafío y a menudo incluye glucocorticoides e inmunosupresores, con respuestas variables. Las terapias hipometilantes y el trasplante alogénico de células progenitoras hematopoyéticas se consideran terapias prometedoras. El pronóstico es influido por factores genéticos y clínicos. El objetivo de esta revisión es proporcionar una visión general sobre la patogénesis, la presentación clínica, el tratamiento y el pronóstico del síndrome de VEXAS para la comunidad médica latinoamericana. VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is an adult-onset autoinflammatory syndrome characterized by somatic mutations in the UBA1 gene and is considered the prototype of hematoinflammatory diseases. Patients with VEXAS syndrome exhibit inflammatory and hematological manifestations that can lead to clinical diagnoses such as relapsing polychondritis, polyarteritis nodosa, Sweet syndrome, and myelodysplastic syndrome. Diagnosis requires bone marrow evaluation to identify cytoplasmic vacuoles in myeloid and erythroid precursors. However, genetic confirmation of mutations in UBA1 is necessary. Treatment is challenging and often involves glucocorticoids and immunosuppressants with variable responses. Hypomethylating agents and allogenic haemopoietic stem cell transplant are considered promising therapies. Prognosis is influenced by genetic and clinical factors. The aim of this review is to provide an overview of the pathogenesis, clinical presentation, treatment, and prognosis of VEXAS syndrome for the Latin American medical community. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Reumatología Clínica is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=174317512
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.reuma.2023.10.006
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 47
    Subjects:
      – SubjectFull: PURE red cell aplasia
        Type: general
      – SubjectFull: STEM cell transplantation
        Type: general
      – SubjectFull: SWEET'S syndrome
        Type: general
      – SubjectFull: POLYARTERITIS nodosa
        Type: general
      – SubjectFull: SYMPTOMS
        Type: general
      – SubjectFull: MYELODYSPLASTIC syndromes
        Type: general
    Titles:
      – TitleFull: Síndrome de VEXAS: manifestaciones clínicas, diagnóstico y tratamiento.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Loeza-Uribe, Michelle Patricia
      – PersonEntity:
          Name:
            NameFull: Hinojosa-Azaola, Andrea
      – PersonEntity:
          Name:
            NameFull: Sánchez-Hernández, Beatriz E.
      – PersonEntity:
          Name:
            NameFull: Crispín, José C.
      – PersonEntity:
          Name:
            NameFull: Apodaca-Chávez, Elia
      – PersonEntity:
          Name:
            NameFull: Ferrada, Marcela A.
      – PersonEntity:
          Name:
            NameFull: Martín-Nares, Eduardo
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1699258X
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Reumatología Clínica
              Type: main
ResultId 1